Is anticoagulant therapy always indicated in “medium-risk” patients with first diagnosed atrial fibrillation? Insights from a real world, 10-year observational study

The choice of antithrombotic prophylaxis in the so-called “medium-risk” patients (i.e., CHA2DS2-VASc score = 1 in males or 2 in females) is one of the major enigmatic issues in clinical management of atrial fibrillation (AF).

Source: International Journal of Cardiology - April 17, 2019 Category: Cardiology Authors: Laura Bonfanti, Giuseppe Lippi, Valentina Donelli, Federica Pigna, Carlotta Saccenti, Gianfranco Cervellin Source Type: research